The Risks of Compounded and Unapproved Tirzepatide The success of GLP-1 medications like Tirzepatide has unfortunately led to the rise of unapproved and compounded versions
Guo M, Gu J, Teng F, Chen J, Ma X, Chen Q, et al
,,SasmazHK,KadirogluPAdalEet al.Optimization of black garlic production parameters using response surface methodology: Assessment and characterization of bioactive properties.2023;34:100477 49
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN-3)
According to clinical trial data reported by reputable sources like the Mayo Clinic and Cleveland Clinic, tirzepatide generally leads to more significant weight loss than semaglutide
Side effects may return after a dose increase and then subside once more as the body adjusts